posted
This stock is impossible. I don't think anything can drive it up anymore than its current price. The volume is too huge, and the Stochastic Oscillator on the chart constantly moves from Oversold to Overbought with only a tiny increase in stock price (it should move sharply up after being oversold). Finally, its trading within its bollinger bands so this suggests that its priced where its supposed to be, not lower. Too many bearish indicaters on this one, in my opinion. No where near a professional, please don't trust me, do your own research. Smash
Posts: 406 | From: San Diego | Registered: Jun 2009
| IP: Logged |
posted
Anyone see this yesterday? Jump today? It came out at 3:15 p.m. yesterday - I didn't see it though.
Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading Medical Device Manufacturer focused in the $8 Billion global Respiratory Markets for the growing aging population and emerging markets for Home (DME), Hospital and Aviation Industries, announced today that the company is ahead of schedule with the debt reduction program, and with export product expansion and distribution.
The company implemented a debt reduction program in March-2009 with efforts focused on operational debts accrued during 2008. To date, the company has paid down all operational debts that were accrued in 2008. "These were debts that we expected to pay off by the end of August-2009; however, we have tightened our belts and paid them off 60 days early," stated Thomas J. Neavitt, Chief Financial Officer. In addition, the company has heavily invested in the marketing and advertising of the new Oxyview Nasal Cannula, using effective publication sources such as COPD Digest and MedCo Forum.
Further, the company is also ahead of schedule with their ISO Certification for export marketing and distribution of their Oxyview product line. Since the introduction of the new Oxyview Nasal Cannula "All-In-One" last week, the company has received hundreds of new distributor inquiries and is now evaluating all of the new distributors. "Ingen is receiving 10-20 new distributor inquiries daily, and this is a difficult process involving due diligence. We want distributors that have been in business for at least 5 years, and have a solid home oxygen patient market in their territory," stated Christopher Wirth, Chief Operations Officer.
"We are all very pleased with the direction this company has taken: reducing our debt, increasing sales and distribution worldwide, and our commitment to our shareholders and their investment. All of these activities play a role in the success and future of this company. We expect to stay ahead of schedule and prosper in the very near future," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.
About Oxyview:
Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S. and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufacturers all of its respiratory products in the United States. There are 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
posted
Saw it, but it hasn't done much good today. I believe next Friday the 10th or Monday 13th will be some good and/or bad days. Next Shareholders meeting is Monday July 13th. We just need some good hard facts.
I don't own any shares of IGNT, so I'm impartial to it. In my opinion, this stock is gonna turn around pretty soon. There have has been one major problem with this ever since its spike up on June 9th. This problem also plagues SPNG (Spongetech). The volume is too high. When there's this kind of trading volume, the ASK price is constantly being undercut, and the BID keeps retracting each time the ASK moves lower. Here's the good thing. The volume since June 29th has been at or near triple digits (in millions), but the last two trading sessions have seen a large volume decline. This, coupled with the fact that a 1.5 month chart shows that the stock is oversold and trading on the lower end of its bollinger band, signals that selling pressure should subside and the stock price should begin to climb back up. The current price of .0055 is the lowest its been since it spiked in June. In my opinion, if you can afford to keep your funds in it, now is a bad time to sell. Always do your own research, and don't base any decisions based on my opinions. Smash
Posts: 406 | From: San Diego | Registered: Jun 2009
| IP: Logged |
posted
Thats what the chart says, and they put out PR a lot. These are the drivers of penny stocks, but their earnings look terrible. I don't know if the report is accurate, because it kind of contradicts their PR. Good luck
Posts: 406 | From: San Diego | Registered: Jun 2009
| IP: Logged |
More News related to IGNT Ingen Hires Firm to Complete GSA Contract for Government Buying Ingen Gears-Up to Introduce New Low-Flow Oxyview Infant Nasal Cannula to Infant and Neonatal Respiratory Markets Letter to Shareholders From Chairman of Ingen Technologies, Inc. Ingen Looks At Acquiring Comfort Medical Supply Ingen Ahead of Schedule With Product Distribution and Debt Reduction More News related to IGNT More News related to Press Releases Research and Markets: Center Telecom [ESMO] Forecast and Comment on Latest Events Tyler Technologies Expands Relationship with Collin County, Texas with New Agreement for Additional Courts and Justice Software Frost & Sullivan: Mobile Operators Rely on Mobile Data Services and Innovative Pricing to Drive Value in North American Mobile Communication Markets AVIATION WEEK Announces Leading Airline Industry Rankings: 2009 Top-Performing Companies New Avaya one-X Agent Helps Businesses Boost Productivity and Efficiency of Virtual Customer Service Operations More News related to Press Releases July 14, 2009 6:45 AM EDT
YUCAIPA, Calif., July 14, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets: IGNT), a leading Global Medical Device manufacturer focused in the $4 Billion U.S. Respiratory Market for the growing aging and emerging markets for Home (DME), Hospital and Aviation Industries, announced today that they have hired KGMA Business Solutions to complete the GSA filing requirements.
The Texas based KGMA was hired to complete the General Services Administration (GSA) and E-Buy filings for Ingen. KGMA maintains relationships with thousands of contracting and small business specialists within the Federal Government and Fortune 500 markets. KGMA will assist Ingen to identify, develop and deliver high-performance businesses to provide cost-effective solutions for Fortune 500 and Government agencies.
GSA serves as the acquisition and procurement arm of the federal government, offering equipment, supplies, telecommunications, and integrated information technology solutions to federal agencies so that the agencies can focus on providing products and services. As the federal government's purchasing agent, GSA connects federal purchasers with the most cost-effective and high-quality commercial products and services.
At any level of government, public purchasers search for good buys. By comparing prices, product quality, delivery terms, added services, and other determining factors, purchasers can be assured that they're spending taxpayer dollars wisely. To help state and local agencies enjoy cost savings and streamlined procedures for procuring medical technology, the U.S. Congress passed legislation to allow cooperative purchasing from federal contracts. The new Oxyview Nasal Cannula would be a very competitive product in the VA Hospitals, VA patients needing home oxygen therapy, and military medical units. The Oxyview Nasal Cannula is priced at $5.75.
"I have enjoyed working with Kenneth Kurk, the CEO of KGMA Business Solutions and I look forward to completing the GSA filing in a swift and efficient manner. We have recently received inquiries from the United States Navy regarding the purchase of our Oxyview products," Stated Scott R. Sand, Chief Executive Officer of Ingen Technologies.
Ingen submitted for GSA in 2007, and was required to meet a specific sales quota before being approved. The company has recently reached the sales quota and expects approval once KGMA has prepared and filed the revised GSA documents.
Posts: 36 | From: Charlotte, NC | Registered: May 2009
| IP: Logged |
posted
Where are the transcripts, highlights, anything from the shareholders meeting yesterday? Did they even have one?
Posts: 44 | From: Florida | Registered: May 2009
| IP: Logged |
posted
Shareholder meeting rescheduled for September 22nd. Greaaaaaaaaaat. Tired of holding onto this one but at this point, I have no choice. I'm praying for good news in September.
Posts: 44 | From: Florida | Registered: May 2009
| IP: Logged |
posted
July 22, 2009 close Email this News Article
IGNT 0.007 -0.0003
Today 5d 1m 3m 1y 5y 10y
Ingen Stocks $2.5 Million in Oxyview Inventory for Future Orders Ingen Stocks $2.5 Million in Oxyview Inventory for Future Orders Investment Bank Commits to Deliver Shareholder Value YUCAIPA, Calif., July 22, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT) a leading Medical Device Manufacturer focused in the $8 Billion global Respiratory Markets for the growing ageing population and emerging markets for Home (DME), Hospital and Aviation Industries announced today that the company has developed $2,500,000 worth of product inventory as a part of the initial strategic relationship with the Pacific Pearl Group and their commitment to assist Ingen Technologies with increased value.
"The distribution of the Company's flagship product -- Oxyview -- in China is an indication that Ingen Technologies recognizes the underserved, respiratory market, where COPD ranks first among the burdens of diseases in the country. Pacific Pearl Group is uniquely positioned to assist Ingen Technologies to assess potential bids from the domestic and international markets, in particular China, and we will simultaneously evaluate other viable strategies in order to deliver shareholder value," stated Reisa Jiang, founder and Chief Executive Officer of Pacific Pearl Group.
Pacific Pearl Group (Member FINRA/SIPC) is a China-focused investment bank dedicated to advising small- and micro-cap companies and privately-held firms. Headquartered in Pasadena, California, Pacific Pearl Group provides a broad array of financial and strategic advisory services to corporate clients including: mergers and acquisitions, private placements, proprietary market research and turnaround management.
The company has initiated the production of 100,000 Oxyview units , with an additional 60,000 Oxyview Nasal Cannula's being delivered in August-2009. The aggressive saturation advertising campaign scheduled in the Fall with COPD Digest, Medco Forum and several others, in combination with restructure and strengthening of the distribution network; Ingen anticipates better earnings than expected in the next few months to come. Despite the fierce cuts in Medicare and low priced cannuals being sold today without an oxyview attached, experts predict strong customer purchase support of the new Oxyview Nasal Cannula simply based on patient demand, and as a means to improve oxygen therapy and an overall savings as a result in a decrease of service calls.
"Ingen is now positioned to create strong revenues, earnings and shareholder profits," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.
Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufacturers all of its respiratory products in the United States. There are 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
-------------------- Please buy responsibly. Do not take my word on any stock. Do your own research. Thanks & good luck! Posts: 439 | From: USA | Registered: Jul 2009
| IP: Logged |
posted
Making the right moves. Increasing my positions in the morning.
Ingen Moves Forward in $40B GSA Schedule for Military and Va Hospitals Thursday 07/30/2009 5:51 PM ET - Globenewswire
Related Companies Symbol Last %Chg CCWF 1.01 0.00% IGNT 0.0058 0.00%
As of 3:57 PM ET 7/30/09 Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading Medical Device Manufacturer focused in the $8 Billion global Respiratory Markets for the growing ageing population and emerging markets for Home (DME), Hospital and Aviation Industries, announced today that the company expects to be listed as a GSA contractor by the end of the year, and at the same time will finalize the ISO certification in order to export the new Oxyview Nasal Cannula to China, Japan, Canada and Europe.
Ingen has prepaid the fees required for the Texas based KGMA Business Solutions, Inc. to finalize the GSA Schedule 65IIA proposal for submission in August-2009. The GSA Schedule 65IIA allows Ingen to be listed under the U.S. General Services Administration as a contractor to sell medical products and services to the military and government owned VA Hospitals. With hundreds of VA Hospitals and more than 25 million veterans, the new Oxyview Nasal Cannnula will be sold into all of the respiratory departments at a contract price of $4.50 each. It is estimated that there are more than 2 million veterans prescribed home oxygen therapy. The company has already placed the new Oxyview Nasal Cannula with several VA Hospitals around the country. Projected GSA sales for Ingen are expected to be $2M annually.
Cheryl Fisher with the Texas based Emergo Group Inc. is scheduled to finalize ISO training on August 17, 2009. The International Standards Organization (ISO) required certification with manufacturers who sell products in designated countries outside the USA. Ingen is a licensed and FDA registered medical device manufacturer. ISO certification allows Ingen to market and sell the new Oxyview Nasal Cannula in China, Japan, Australia, Canada and Europe, with projected sales of $200M annually.
"Ingen will be GSA listed and ISO certified in time to launch the new Oxyview Nasal Cannula in to new government markets and world markets. This can only strengthen sales and earnings for our shareholders. The company is now preparing for a share buy-back program as a part of strengthening the share price. There are no reverse splits considered now or in the future. The shareholders must be considered first, and our products and revenues will blaze a new trail for this company," stated Scott R. Sand, Chief Financial Officer and Chairman of the Board.
Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 Billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufacturers all of its respiratory products in the United States. There are 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
Ingen Technologies, Inc. Chris Wirth 909-790-7180 info*ingen-tech.com www.INGEN-TECH.COMPosts: 44 | From: Florida | Registered: May 2009
| IP: Logged |
posted
Do these guys always put out their good PRs after-hours? Looks like the last 3 have been around 5pm??
I missed this on June 9th - didn't get filled and wouldn't chase it - I was not a happy camper.
I'm thinking seriously of getting in tomorrow and trying to go for a double here and KEEPING the winnings here. Looks like it's got quite a future! I can't believe HArt to Treat Diseases never made it ti the big boards - I used to follow them 6 or 7 years ago - Can't remember - but my hair wasn't as gray then! :-)
Does Oxyview require a prescription, like some devices? I would think the oxygen cylinders require one - maybe devices like Oxyview already come with them? Does anyone know if doctors are prescribing this device to patients now? I'll have to call my pulmonary doctor or ask my cardiologist when I have my appointment Tuesday. I'll let you all know if they know about Oxyview.
Thanks in advance for your responses. Steve
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
Hey all - Has anyone REALLY checked out the background of this company? It looks like they've already done at least 3 RS's....Ewwww
I just went over to ihub to read the threads on this stock there - WOW - there's a poster called 'stockmasterflash' who REALLY has nothing good to say about this CEO - and looks like he backs it up with fact. Doesn't sound like a typical know-nothing basher, imho. Looks like this is super-diluted....AND They've paid that P&D mill OTC Reporter 148,000,000 million shares recently that have all been sold. PLUS they're being sued by a hedgefund or co. that they owe over $5,000,000 to; says: "AJW seeking to foreclose on Ingen's assets" - and the court case and proceedings - which are going on NOW - are documented. So we should all be careful. I've been burned in 8-12 RS's before - you lose all your investment in that stock.
Not trying to get anyone shaken up - most of the pinkies and OTCs are on shaky ground - and recently so are the (former) Big Boys. I just don't want to see anyone here get hurt - including me!
Tonight's PR looked GREAT - ability to contract with GSA, Military, VA - but I'm re-thinking my previous thinking and if I do buy today - I'm looking to trade it and take profits whenever possible and not leave anything to possibly ride into another RS.
Looks like they've got a great product but not a great leader? Your thoughts and any further DD please?
Thanks, Steve
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
Tex - what do you think - Day by Day PLAY - or Stay Away? I know a LOT of people have made money with this already - I never got filled a while back and decidend NOT to chase it. Oh well - was one I should have chased! But then it would have dropped like a rock. I'm VERY leary of Pinks.
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
Tex - remember some of us put together a list of the WORST Reverse Split Repeat Offenders back in August of 2005? Here is a post I made back then of stocks that I got caught in, and a list people on ihub made up too..... In fact Indiginet, which got me pretty good back then - is STILL around - I posted about them on a thread here in the past 3-6 weeks. I'm gonna put my old post from 4 years ago here - but maybe we should get a list together again - so good people don't get burned....
Steve - and here's my post from 4 summers ago - WOW. And I'm not rich YET! LOL
Love the Market Member
Member Rated: posted August 28, 2005 20:06 -------------------------------------------------------------------------------- A few that come to mind are: Gateway (was GTWY and a bunch of other symbols), Core Solutions CSOU, - changed it's name I believe) American Fire Retardant (AFRR, AFRT and other symbols), Indiginet (IDGE, IDGN and other symbols). Here's a link to more:
posted
Love, that would be a wonderful thing to do for us - THANKS!
-------------------- Please buy responsibly. Do not take my word on any stock. Do your own research. Thanks & good luck! Posts: 439 | From: USA | Registered: Jul 2009
| IP: Logged |
posted
Looky, Ticker is here too! Do me a favor and sell if you have any, so the stock will rise like EVRM. Just kidding you.
I've been sitting on this one (.003 and .01). The company seems to always post after hours and post almost to much. The latest news sounds great and comments on no reverse split, while also trying a share buy-back program to raise value. The company seems to have a bad history, but if he doesn't stick to his word on this one, they'll lose everything, IMO.
Posts: 36 | From: Charlotte, NC | Registered: May 2009
| IP: Logged |
quote:Originally posted by Love the Market: Tex - remember some of us put together a list of the WORST Reverse Split Repeat Offenders back in August of 2005? Here is a post I made back then of stocks that I got caught in, and a list people on ihub made up too..... In fact Indiginet, which got me pretty good back then - is STILL around - I posted about them on a thread here in the past 3-6 weeks. I'm gonna put my old post from 4 years ago here - but maybe we should get a list together again - so good people don't get burned....
Steve - and here's my post from 4 summers ago - WOW. And I'm not rich YET! LOL
Love the Market Member
Member Rated: posted August 28, 2005 20:06 -------------------------------------------------------------------------------- A few that come to mind are: Gateway (was GTWY and a bunch of other symbols), Core Solutions CSOU, - changed it's name I believe) American Fire Retardant (AFRR, AFRT and other symbols), Indiginet (IDGE, IDGN and other symbols). Here's a link to more:
"The Plantiff is AJW Partners, and lists a total of ten business variants of AJW partners as the plantiff. They're all registered as businesses in the Cayman Islands, being managed in New York.
Next stop, search plantiff, entering just AJW parnters. Here's all the lawsuits they've filed starting in 2002
Search results? THIRTY SIX. OK, there ARE a couple that were filed using a couple variants of AJW Parters at the same time as plantiff. But only a couple.
Then I started checking the actual lawsuits:
Central Wireless Inc. 9/2005 Summons filed, nothing else ever done.
Positran Corp 6/09 nothing scanned (unknown)
Uncommon Media Group Inc. 12/2005 decision, taken off calendar per plantiff request.
Roanoke Technology Corp: 3/2004. Decision 2/2006, withdrawn per plantiff request
Peak Entertainment Holdings. 7/05. Decision. Defendant failed to repurchase shares according to agreement. Judgement in favor of plantiff 10/2008
Valcom Inc. 9/2005, nothing further.
US Wireless INC. 12/2005, ntohing further
Femone INC. 2/2006, nothing further.
I could go on and on, but you get the idea.
Then I Googled AJW Partners, found out they run a hedge fund. Interesting stuff to follow;
N.I.R. Group is a division of AJW Partners.
N.I.R. Group Plays Rough with Investors who Speak Out, Demand to See Books - Dealbreaker - A Wall Street Tabloid - Business News Headlines and Financial Gossip
"But Dealbreaker has learned that well before Steven Mizel and Palmetto Partners filed suit in March, NIR, based in the Long Island suburb of Roslyn and founded by 38-year-old Corey Ribotsky, had tried to bribe an investor from going to the press after NIR suspended redemptions on its AJW Partners Fund back in October 2008."
"Call it Madoff-on-Steroids.: (that made me laugh)
Hedge Fund Accused Of Bogus Returns - Forbes.com
"A Long Island hedge fund known for making controversial deals in penny stocks continues to be accused by its investors of making up its returns."
Lastly, I found this. I have not verified the facts, but it IS interesting reading;
Deep Capture Forums / N.I.R. Group Plays Rough with Investors who Speak Out, Demand to See B
"Yet all is not rosy for Ribotsky, according to internal SEC documents seen by Dealbreaker. As of May 2008, the fund was being investigated, but no charges have been made. Sources close to the fund, who have also spoken to the SEC, say that the regulator is likely looking at securities fraud as allegedly the firm also shorts the stock of the companies it lends to. This type of trading is illegal because it breaks the convents of its PIPE loan terms. Additional a source who has worked with fund says the principal value of it notes are inflated because Ribotsky just rewrites the notes and adds paper profits to the original principal- what could not be clarified is how much of a management fee are investors paying on that paper asset value."
So, yes there is a lawsuit. But taking all the facts into consideration may be a good idea." __________________
-------------------- Please buy responsibly. Do not take my word on any stock. Do your own research. Thanks & good luck! Posts: 439 | From: USA | Registered: Jul 2009
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
![[Wall Bang]](graemlins/wallbang.gif)
![[Big Grin]](biggrin.gif)
![[Wink]](wink.gif)
Just kidding you.
